Follow the people · Insider
Barry Ticho
Barry Ticho files insider transactions with the SEC as a chief medical officer of Stoke Therapeutics (STOK). We hold 10 disclosed purchases and sales filed since 26 March 2020, 4 of them in the last 90 days.
- Files forSTOK
- Disclosed buys and sells10 in all, 4 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 March 2020 — 1 September 2026Chief Medical Officer · Stoke Therapeutics (STOK)161 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,945 shares of Stoke TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 1,600 shares of Stoke TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 418 August 2026Common Stock · traded 14 August 2026 · filed 18 August 2026
- ▼ sold on the open market 4,525 shares of Stoke TherapeuticsSEC Form 418 August 2026Common Stock · traded 18 August 2026 · filed 18 August 2026
- ▼ sold on the open market 242 shares of Stoke TherapeuticsSEC Form 418 August 2026Common Stock · traded 18 August 2026 · filed 18 August 2026
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 August 2026Performance Stock Units · traded 14 August 2026 · filed 18 August 2026
- ▼ sold on the open market 5,907 shares of Stoke TherapeuticsSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 1,269 shares of Stoke TherapeuticsSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 6,728 shares of Stoke TherapeuticsSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 500 shares of Stoke TherapeuticsSEC Form 46 July 2026Common Stock · traded 1 July 2026 · filed 6 July 2026
- ▼ sold on the open market 1,795 shares of Stoke TherapeuticsSEC Form 43 June 2026Common Stock · traded 1 June 2026 · filed 3 June 2026
- ▼ sold on the open market 2,243 shares of Stoke TherapeuticsSEC Form 45 May 2026Common Stock · traded 1 May 2026 · filed 5 May 2026
- ▼ sold on the open market 1,838 shares of Stoke TherapeuticsSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 3,577 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 2,587 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 6,100 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- exercised options over 1,365 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 March 2026Stock Option (Right to Buy) · traded 19 March 2026 · filed 19 March 2026
- ▼ sold on the open market 483 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 103 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- exercised options over 1,365 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- ▼ sold on the open market 1,461 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- exercised options over 1,365 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 March 2026Stock Option (Right to Buy) · traded 19 March 2026 · filed 19 March 2026
- ▼ sold on the open market 3,577 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 2,587 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 17 March 2026 · filed 19 March 2026
- ▼ sold on the open market 6,100 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 483 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- ▼ sold on the open market 103 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 18 March 2026 · filed 19 March 2026
- exercised options over 1,365 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- ▼ sold on the open market 1,461 shares of Stoke TherapeuticsSEC Form 419 March 2026Common Stock · traded 19 March 2026 · filed 19 March 2026
- exercised options over 13,100 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,750 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 13,100 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,750 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 13,100 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,750 shares of Stoke Therapeutics (a derivative holding)SEC Form 417 March 2026Restricted Stock Units · traded 15 March 2026 · filed 17 March 2026
- exercised options over 13,100 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- exercised options over 10,750 shares of Stoke TherapeuticsSEC Form 417 March 2026Common Stock · traded 15 March 2026 · filed 17 March 2026
- was granted 60,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Employee Stock Option (Right to Buy) · traded 17 February 2026 · filed 19 February 2026
- was granted 40,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Restricted Stock Units · traded 17 February 2026 · filed 19 February 2026
- was granted 60,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Employee Stock Option (Right to Buy) · traded 17 February 2026 · filed 19 February 2026
- was granted 40,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 February 2026Restricted Stock Units · traded 17 February 2026 · filed 19 February 2026
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2025Performance Stock Units · traded 3 December 2025 · filed 5 December 2025
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 3 December 2025 · filed 5 December 2025
- ▼ sold on the open market 1,373 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 4 December 2025 · filed 5 December 2025
- ▼ sold on the open market 323 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 4 December 2025 · filed 5 December 2025
- ▼ sold on the open market 1,673 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 5 December 2025 · filed 5 December 2025
- ▼ sold on the open market 1,989 shares of Stoke TherapeuticsSEC Form 45 December 2025Common Stock · traded 5 December 2025 · filed 5 December 2025
- exercised options over 11,981 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 December 2025Restricted Stock Units · traded 1 December 2025 · filed 3 December 2025
- exercised options over 11,981 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 1 December 2025 · filed 3 December 2025
- ▼ sold on the open market 1,244 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 762 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 2 December 2025 · filed 3 December 2025
- ▼ sold on the open market 789 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 3 December 2025 · filed 3 December 2025
- ▼ sold on the open market 1,225 shares of Stoke TherapeuticsSEC Form 43 December 2025Common Stock · traded 3 December 2025 · filed 3 December 2025
- ▼ sold on the open market 3,776 shares of Stoke TherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 1,455 shares of Stoke TherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 600 shares of Stoke TherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 100 shares of Stoke TherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 5,343 shares of Stoke TherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- ▼ sold on the open market 5,501 shares of Stoke TherapeuticsSEC Form 43 September 2025Common Stock · traded 2 September 2025 · filed 3 September 2025
- ▼ sold on the open market 2,805 shares of Stoke TherapeuticsSEC Form 420 August 2025Common Stock · traded 18 August 2025 · filed 20 August 2025
- was granted 20,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 August 2025Performance Stock Units · traded 14 August 2025 · filed 18 August 2025
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 August 2025Performance Stock Units · traded 14 August 2025 · filed 18 August 2025
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 418 August 2025Common Stock · traded 14 August 2025 · filed 18 August 2025
- ▼ sold on the open market 4,504 shares of Stoke TherapeuticsSEC Form 45 August 2025Common Stock · traded 1 August 2025 · filed 5 August 2025
- ▼ sold on the open market 4,503 shares of Stoke TherapeuticsSEC Form 42 July 2025Common Stock · traded 1 July 2025 · filed 2 July 2025
- ▼ sold on the open market 1,745 shares of Stoke TherapeuticsSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- ▼ sold on the open market 6,471 shares of Stoke TherapeuticsSEC Form 44 June 2025Common Stock · traded 3 June 2025 · filed 4 June 2025
- ▼ sold on the open market 3,841 shares of Stoke TherapeuticsSEC Form 45 May 2025Common Stock · traded 1 May 2025 · filed 5 May 2025
- ▼ sold on the open market 22,790 shares of Stoke TherapeuticsSEC Form 45 May 2025Common Stock · traded 2 May 2025 · filed 5 May 2025
- was granted 64,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 420 March 2025Employee Stock Option (Right to Buy) · traded 20 March 2025 · filed 20 March 2025
- was granted 43,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 420 March 2025Restricted Stock Units · traded 20 March 2025 · filed 20 March 2025
- ▼ sold on the open market 3,884 shares of Stoke TherapeuticsSEC Form 420 March 2025Common Stock · traded 18 March 2025 · filed 20 March 2025
- ▼ sold on the open market 3,333 shares of Stoke TherapeuticsSEC Form 420 March 2025Common Stock · traded 19 March 2025 · filed 20 March 2025
- exercised options over 13,100 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 March 2025Restricted Stock Units · traded 15 March 2025 · filed 18 March 2025
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 418 March 2025Restricted Stock Units · traded 15 March 2025 · filed 18 March 2025
- exercised options over 13,100 shares of Stoke TherapeuticsSEC Form 418 March 2025Common Stock · traded 15 March 2025 · filed 18 March 2025
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 418 March 2025Common Stock · traded 15 March 2025 · filed 18 March 2025
- ▼ sold on the open market 2,586 shares of Stoke TherapeuticsSEC Form 411 December 2024Common Stock · traded 9 December 2024 · filed 11 December 2024
- ▼ sold on the open market 13,945 shares of Stoke TherapeuticsSEC Form 410 December 2024Common Stock · traded 6 December 2024 · filed 10 December 2024
- was granted 20,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2024Performance Stock Units · traded 3 December 2024 · filed 5 December 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 December 2024Performance Stock Units · traded 3 December 2024 · filed 5 December 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 45 December 2024Common Stock · traded 3 December 2024 · filed 5 December 2024
- exercised options over 48,792 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 December 2024Restricted Stock Unit (RSU) · traded 1 December 2024 · filed 3 December 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 December 2024Stock Option (Right to Buy) · traded 2 December 2024 · filed 3 December 2024
- exercised options over 48,792 shares of Stoke TherapeuticsSEC Form 43 December 2024Common Stock · traded 1 December 2024 · filed 3 December 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- ▼ sold on the open market 10,000 shares of Stoke TherapeuticsSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 November 2024Stock Option (Right to Buy) · traded 1 November 2024 · filed 5 November 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- ▼ sold on the open market 10,000 shares of Stoke TherapeuticsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 42 October 2024Stock Option (Right to Buy) · traded 1 October 2024 · filed 2 October 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 42 October 2024Common Stock · traded 1 October 2024 · filed 2 October 2024
- ▼ sold on the open market 10,000 shares of Stoke TherapeuticsSEC Form 42 October 2024Common Stock · traded 1 October 2024 · filed 2 October 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 September 2024Stock Option (Right to Buy) · traded 3 September 2024 · filed 5 September 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 9,400 shares of Stoke TherapeuticsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- ▼ sold on the open market 600 shares of Stoke TherapeuticsSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 August 2024Stock Option (Right to Buy) · traded 1 August 2024 · filed 5 August 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- ▼ sold on the open market 10,000 shares of Stoke TherapeuticsSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 July 2024Stock Option (Right to Buy) · traded 1 July 2024 · filed 3 July 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 43 July 2024Common Stock · traded 1 July 2024 · filed 3 July 2024
- ▼ sold on the open market 10,000 shares of Stoke TherapeuticsSEC Form 43 July 2024Common Stock · traded 1 July 2024 · filed 3 July 2024
- was granted 60,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 47 June 2024Employee Stock Option (Right to Buy) · traded 27 March 2024 · filed 7 June 2024
- was granted 40,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 47 June 2024Restricted Stock Units · traded 27 March 2024 · filed 7 June 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 45 June 2024Stock Option (Right to Buy) · traded 3 June 2024 · filed 5 June 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 9,897 shares of Stoke TherapeuticsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- ▼ sold on the open market 103 shares of Stoke TherapeuticsSEC Form 45 June 2024Common Stock · traded 3 June 2024 · filed 5 June 2024
- exercised options over 10,000 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 May 2024Stock Option (Right to Buy) · traded 1 May 2024 · filed 3 May 2024
- exercised options over 10,000 shares of Stoke TherapeuticsSEC Form 43 May 2024Common Stock · traded 1 May 2024 · filed 3 May 2024
- ▼ sold on the open market 10,000 shares of Stoke TherapeuticsSEC Form 43 May 2024Common Stock · traded 1 May 2024 · filed 3 May 2024
- exercised options over 442 shares of Stoke Therapeutics (a derivative holding)SEC Form 43 April 2024Stock Option (Right to Buy) · traded 1 April 2024 · filed 3 April 2024
- exercised options over 442 shares of Stoke TherapeuticsSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 9,426 shares of Stoke TherapeuticsSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- exercised options over 13,100 shares of Stoke Therapeutics (a derivative holding)SEC Form 419 March 2024Restricted Stock Units · traded 15 March 2024 · filed 19 March 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.